Vanda Pharmaceuticals
VNDA
#7861
Rank
S$0.41 B
Marketcap
S$6.98
Share price
3.65%
Change (1 day)
7.60%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Cash on Hand

Cash on Hand as of September 2025 : S$0.38 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has S$0.38 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.50 B-0.69%
2023-12-31S$0.51 B-18.07%
2022-12-31S$0.62 B6.96%
2021-12-31S$0.58 B20.27%
2020-12-31S$0.48 B15.61%
2019-12-31S$0.42 B19.69%
2018-12-31S$0.35 B83.3%
2017-12-31S$0.19 B-6.23%
2016-12-31S$0.20 B1%
2015-12-31S$0.20 B18.07%
2014-12-31S$0.17 B3.87%
2013-12-31S$0.16 B12.16%
2012-12-31S$0.14 B-23.64%
2011-12-31S$0.19 B-24.42%
2010-12-31S$0.25 B-11.49%
2009-12-31S$0.28 B333.8%
2008-12-31S$66.43 M-45.79%
2007-12-31S$0.12 B150.79%
2006-12-31S$48.87 M-5.78%
2005-12-31S$51.87 M95.55%
2004-12-31S$26.52 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
S$12.63 B 3,220.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$12.84 B 3,274.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$24.05 B 6,218.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$21.38 B 5,517.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$19.41 B 5,000.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
S$3.63 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$23.60 B 6,100.47%๐Ÿ‡บ๐Ÿ‡ธ USA